
Brigham Buhler (2026) - Personalized Medicine, Biotechnology & Peptides
This recap episode features a detailed conversation with Brigham Buhler regarding the future of personalized medicine and the regulatory challenges facing peptides and stem cell therapies. The discussion highlights how big pharma lobbying and medical dogma often obstruct access to innovative treatments like hormone replacement therapy and regenerative biologics. Buhler explains the potential of Muse cells and gene sequencing to move healthcare from a reactive "sick care" model to a proactive longevity-based system. He advocates for a cash-pay "life raft" that allows patients to maintain…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.